VENCLEXTA (venetoclax) Patient Assistance Program
Don’t let the high cost of brand specialty BCL-2 inhibitor therapy stand between you and
the treatment you need. We help eligible patients access Venclexta (venetoclax) for as
little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Venclexta (venetoclax) is FDA-approved for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) — used as a single agent or in combination with rituximab or obinutuzumab — and for newly-diagnosed acute myeloid leukemia (AML) in adults 75 and older or those ineligible for intensive chemotherapy, in combination with azacitidine, decitabine, or low-dose cytarabine.
- Without assistance, the retail cost commonly runs approximately $13,000–$15,000 per 30-day supply at the standard 400 mg daily dose.
- Through AffordMyPrescriptions, qualifying patients can access Venclexta for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Venclexta available in the U.S. as of 2026.
What is Venclexta Prescription Assistance Program?
The Venclexta Prescription Assistance Program is a manufacturer-sponsored initiative that provides Venclexta at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for CLL/SLL or AML patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries. Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, tumor-lysis-syndrome ramp-up monitoring, specialty pharmacy logistics, and renewal deadlines. AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Venclexta costs roughly $13,000–$15,000 per 30-day supply at retail pharmacies. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (per dose) | ~$14,500.00 | Save ~$14,430/dose |
| CVS Pharmacy (per dose) | ~$15,000.00 | Save ~$14,930/dose |
| Walmart (per dose) | ~$13,800.00 | Save ~$13,730/mo |
| Costco (per dose) | ~$13,500.00 | Save ~$13,430/mo |
| GoodRx Best Price | ~$13,000.00 | Save ~$12,930/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Venclexta Prescription Program?
The Patient Assistance Program is free to apply for and provides Venclexta at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-authorization documentation, careful ramp-up monitoring during the first 5 weeks of therapy (to prevent tumor lysis syndrome), specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here's why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Venclexta:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $13,000–$15,000 per month even
with the best discountCannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Venclexta assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Vidaza Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Venclexta:
Venclexta (venetoclax) is an oral, targeted oncology medicine — a selective BCL-2 inhibitor — used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy. It is taken once daily and follows a strict 5-week dose ramp-up schedule when starting therapy to prevent tumor lysis syndrome.
How It Works:
BCL-2 (B-cell lymphoma 2) is a protein that prevents cells from undergoing programmed cell death (apoptosis). Many cancer cells — particularly CLL/SLL cells and some AML cells — overexpress BCL- 2, which keeps them alive when they should normally die. This BCL-2 dependence is a vulnerability
that can be targeted therapeutically. Venclexta is a selective BCL-2 inhibitor that binds to BCL-2 and displaces pro-apoptotic proteins,
restoring the cell's ability to undergo programmed death. By tipping the balance back toward apoptosis, Venclexta induces cancer-cell death — often producing rapid and deep responses in CLL and AML. The rapid cell-death response is also why a careful ramp-up dosing schedule is required to prevent
tumor lysis syndrome (a metabolic emergency from massive cell breakdown).
Form and Use:
Venclexta is taken once daily by mouth, with food. For CLL/SLL, the standard target dose is 400 mg daily, but you start with a 5-week dose-escalation schedule (20 mg → 50 mg → 100 mg → 200 mg →400 mg) to mitigate tumor-lysis-syndrome risk. For AML, the dose is 400 mg daily after a 3-day ramp- up. Tablets should be swallowed whole.
Generic Availability:
There is no FDA-approved generic version of Venclexta in the U.S. as of 2026. Other treatment options for CLL/SLL include BTK inhibitors (ibrutinib, acalabrutinib, zanubrutinib, pirtobrutinib), PI3K inhibitors, anti-CD20 antibodies (rituximab with biosimilars, obinutuzumab), and chemoimmunotherapy. For AML, options include hypomethylating agents (azacitidine — generic available, decitabine), FLT3 inhibitors, IDH inhibitors, and CD33-targeted therapy.
Warnings:
Important warnings include tumor lysis syndrome (TLS — a metabolic emergency that can occur when many cancer cells die rapidly; the 5-week ramp-up and prophylactic measures are required to mitigate), neutropenia, infections, immunizations (live vaccines should not be given), and embryo-fetal toxicity.
Your oncology team will monitor blood counts, electrolytes, and kidney function frequently during the ramp-up period and continue monitoring throughout therapy.
FAQ (Frequently Asked Questions)
How Much Does Venclexta Cost Without Insurance?+
The retail price commonly runs $13,000–$15,000 per 30-day supply at the standard 400 mg daily dose. Through AffordMyPrescriptions, qualifying patients receive Venclexta at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Is The 5-Week Ramp-Up Schedule, And Why Is It Required?+
Venclexta starts at a low dose (20 mg) and increases weekly over 5 weeks (20 → 50 → 100 →200 → 400 mg) to prevent tumor lysis syndrome (TLS) — a metabolic emergency from massive cancer-cell death. During the ramp-up, you”ll have frequent blood tests to monitor electrolytes,kidney function, and blood counts. Hydration and prophylactic medications (allopurinol or
rasburicase) are typically given.
How Is Venclexta Taken?+
Venclexta is taken once daily by mouth, with food, at roughly the same time each day. The first 5 weeks follow a structured dose-escalation (for CLL/SLL) to prevent tumor lysis syndrome. After reaching the target 400 mg daily dose, treatment continues for a defined duration (12–24 months for some CLL combinations) or until progression.
Can I Get Venclexta Through The PAP If I Have Medicare?+
Yes. Medicare Part D beneficiaries can typically qualify for Venclexta Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer's commercial copay savings program is reserved for commercially insured patients only — but the underlying
PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?+
If your initial application is denied, we explore alternatives — the manufacturer’s copay assistance program if you have commercial insurance, independent foundations such as the PAN Foundation, HealthWell Foundation, or the Leukemia & Lymphoma Society Co-Pay Assistance Program, or asking your oncology team whether a BTK inhibitor or different treatment would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Venclexta, our team may be able to help you
access assistance programs designed to make brand specialty BCL-2 inhibitor therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.